Polynovo (ASX:PNV) FFO


ASX:PNV Polynovo Ltd ASX:PNV
76 GF Score
Price A$0.91
GF Value A$3.24
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Polynovo FFO?

FFO (Funds from operations) only applies to REITs.

ASX:PNV
76GF Score
Polynovo Ltd ASX:PNV
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Polynovo (ASX:PNV) Overvalued in 2026?

Based on GuruFocus' analysis, Polynovo stock appears to be undervalued. The current stock price of A$0.91 is trading 71.9% below its estimated GF Value™ of A$3.24. GuruFocus considers Polynovo to be Significantly Undervalued.

Key valuation signals for ASX:PNV:

  • FFO:
  • GF Value™: A$3.24 vs. price of A$0.91 (71.9% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the ASX:PNV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Polynovo Business Description

Other Exchanges CALZF:USAMFJ:Germany
Address 320 Lorimer Street, Unit 2, Port Melbourne, VIC, AUS, 3207
Polynovo earns most of its revenue from US sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.
76GF Score

Get the complete analysis for ASX:PNV

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.91
Price
A$3.24
GF Value